Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Schizophrenia Research|February 22, 2005
Olfactory functions and volumetric measures of orbitofrontal and limbic regions in schizophreniaClaudia I Rupp, W Wolfgang Fleischhacker, Georg Kemmler, et al.
Schizophrenia Bulletin|March 10, 2015
Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for interventionRichard J Drake, Merete Nordentoft, Gillian Haddock, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching AntipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Schizophrenia Bulletin|March 12, 2015
The promise of biological markers for treatment response in first-episode psychosis: a systematic reviewGuillaume Fond, Marc-Antoine d'Albis, Stéphane Jamain, et al.
Archives of General Psychiatry|May 9, 2012
Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gainAnil K Malhotra, Christoph U Correll, Nabilah I Chowdhury, et al.
Psychotherapy and Psychosomatics|February 19, 2026
Identifying Transdiagnostic Predictors of Depression Across Psychoses: Informing Stratified Antidepressant TreatmentsSergio Mena, Fiona Coutts, Jana von Trott, et al.
The Lancet. Psychiatry|September 20, 2024
Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negativeJurjen J Luykx, Robbert Visscher, Inge Winter-van Rossum, et al.
The Lancet. Psychiatry|January 30, 2023
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)Inge Winter-van Rossum, Mark Weiser, Silvana Galderisi, et al.
Lancet (London, England)|April 1, 2008
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trialRené S Kahn, W Wolfgang Fleischhacker, Han Boter, et al.
Pageof 17